Select acquires remainder of subsidiaries
By Melissa Trudinger
Tuesday, 30 November, 2004
Tuesday, 30 November, 2004
Select Vaccines (ASX: SLT) will acquire the remaining 35 per cent of its two subsidiaries Picoral and Hepgenics from the Burnet Institute.
The institute will be issued 4 million new shares plus 2 million options in Select Vaccines in return for its equity.
Ongoing R&D programs being conducted by the Burnet Institute for the two companies will continue to be funded through December 2005.
Related News
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
